Form 4 for ORMP ORAMED PHARMACEUTICALS INC.
Accepted 2025-06-09 00:00:00 ET · period of report 2025-06-05 · accession 0001213900-25-052624 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-06-09 | 2025-06-05 | ORMP | Mayer Arie | Dir | A - Grant | — | +37.0K | 133.1K | +38% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-05 | A | A | 30,000 | — | 126,134 | D | — | — | (F1) Represents Restricted Stock Units ("RSUs") that will vest in equal portions of 10,000 as follows: January 1, 2026, January 1, 2027 and January 1, 2028. The RSUs convert into the Issuer's Common Stock on a one-for-one basis. |
| 2 | Common | Common Stock | 2025-06-05 | A | A | 6,975 | — | 133,109 | D | — | — | (F2) Represents RSUs that will vest in equal installments as follows: on grant, July 1, 2025, October 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis. |